4//SEC Filing
DE GREEF RODERICK 4
Accession 0001628280-25-052129
CIK 0000834365other
Filed
Nov 12, 7:00 PM ET
Accepted
Nov 13, 5:18 PM ET
Size
8.9 KB
Accession
0001628280-25-052129
Insider Transaction Report
Form 4
DE GREEF RODERICK
Director
Transactions
- Sale
Common Stock
2025-11-11$26.15/sh−35,417$926,155→ 454,581 total - Sale
Common Stock
2025-11-12$25.88/sh−33,418$864,858→ 421,163 total - Sale
Common Stock
2025-11-13$25.33/sh−31,165$789,409→ 389,998 total
Footnotes (3)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.85 to $26.63, inclusive. The reporting person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.64 to $26.40, inclusive. The reporting person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.05 to $25.87, inclusive. The reporting person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
Documents
Issuer
BIOLIFE SOLUTIONS INC
CIK 0000834365
Entity typeother
Related Parties
1- filerCIK 0001241181
Filing Metadata
- Form type
- 4
- Filed
- Nov 12, 7:00 PM ET
- Accepted
- Nov 13, 5:18 PM ET
- Size
- 8.9 KB